Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS

BACKGROUND: The COVID-19 pandemic reached Germany in spring 2020. No proven treatment for SARS-CoV-2 was available at that time, especially for severe COVID-19-induced ARDS. We determined whether the infusion of mesenchymal stromal cells (MSCs) would help to improve pulmonary function and overall ou...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Intensive Care Med
Prif Awduron: Häberle, Helene, Magunia, Harry, Lang, Peter, Gloeckner, Henning, Körner, Andreas, Koeppen, Michael, Backchoul, Tamam, Malek, Nisar, Handgretinger, Rupert, Rosenberger, Peter, Mirakaj, Valbona
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: SAGE Publications 2021
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8145440/
https://ncbi.nlm.nih.gov/pubmed/33663244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0885066621997365
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg